PCI Biotech (Norway) Today
| PCIB Stock | NOK 1.68 0.11 6.15% |
Performance0 of 100
| Odds Of DistressLess than 10
|
PCI Biotech is selling for 1.68 as of the 18th of April 2024. This is a -6.15 percent decrease since the beginning of the trading day. The stock's lowest day price was 1.66. PCI Biotech has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. Equity ratings for PCI Biotech Holding are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 24th of April 2023 and ending today, the 18th of April 2024. Click here to learn more.
PCI Biotech Holding ASA, a biopharmaceutical company, focuses on the development and commercialization of novel therapies for the treatment of cancer through its photochemical internalization technology platform. PCI Biotech Holding ASA was founded in 2000 and is headquartered in Oslo, Norway. The company has 37.33 M outstanding shares. More on PCI Biotech Holding
Moving together with PCI Stock
| 0.8 | ORK | Orkla ASA | PairCorr |
Moving against PCI Stock
| 0.58 | OLT | Olav Thon Eien | PairCorr |
| 0.43 | RING | Sparebank 1 Ringerike | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
PCI Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. PCI Biotech's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding PCI Biotech or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Per Walday |
| Thematic Idea | IT (View all Themes) |
| Business Concentration | IT, Health Care, Biotechnology, Biotechnology, Healthcare, Computing (View all Sectors) |
PCI Biotech Holding (PCIB) is traded on Oslo Stock Exchange in Norway and employs 14 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 81.93 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate PCI Biotech's market, we take the total number of its shares issued and multiply it by PCI Biotech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. PCI Biotech Holding operates under Biotechnology sector and is part of Health Care industry. The entity has 37.33 M outstanding shares.
PCI Biotech Holding has accumulated about 116.12 M in cash with (68.31 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.83, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check PCI Biotech Probability Of Bankruptcy
Ownership AllocationPCI Biotech owns a total of 37.33 Million outstanding shares. PCI Biotech Holding has substantial amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company maintains, if the real value of the entity is less than the current market value, you may not be able to make money on it.
Check PCI Ownership Details
PCI Stock Price Odds Analysis
Proceeding from a normal probability distribution, the odds of PCI Biotech jumping above the current price in 90 days from now is about 85.31%. The PCI Biotech Holding probability density function shows the probability of PCI Biotech stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon PCI Biotech Holding has a beta of -0.3389 indicating as returns on the benchmark increase, returns on holding PCI Biotech are expected to decrease at a much lower rate. During a bear market, however, PCI Biotech Holding is likely to outperform the market. Additionally, pCI Biotech Holding has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of PCI Biotech to move above the current price in 90 days from now is about 85.31 (This PCI Biotech Holding probability density function shows the probability of PCI Stock to fall within a particular range of prices over 90 days) .
PCI Biotech Holding Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. PCI Biotech market risk premium is the additional return an investor will receive from holding PCI Biotech long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in PCI Biotech. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although PCI Biotech's alpha and beta are two of the key measurements used to evaluate PCI Biotech's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.56 | |||
| Standard Deviation | 3.27 | |||
| Variance | 10.69 | |||
| Risk Adjusted Performance | (0.07) |
PCI Stock Against Markets
Picking the right benchmark for PCI Biotech stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in PCI Biotech stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for PCI Biotech is critical whether you are bullish or bearish towards PCI Biotech Holding at a given time. Please also check how PCI Biotech's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in PCI Biotech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Risk-Return Analysis Now
Risk-Return AnalysisView associations between returns expected from investment and the risk you assume |
| All Next | Launch Module |
PCI Biotech Corporate Directors
PCI Biotech corporate directors refer to members of a PCI Biotech board of directors. The board of directors generally takes responsibility for the PCI Biotech's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of PCI Biotech's board members must vote for the resolution. The PCI Biotech board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Hans Bohn | Director | Profile | |
| Hilde Furberg | Director | Profile | |
| Kjetil Tasken | Director | Profile | |
| Lars Viksmoen | Director | Profile |
How to buy PCI Stock?
Before investing in PCI Biotech, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in PCI Biotech. To buy PCI Biotech stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of PCI Biotech. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase PCI Biotech stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located PCI Biotech Holding stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased PCI Biotech Holding stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as PCI Biotech Holding, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in PCI Biotech Holding?
The danger of trading PCI Biotech Holding is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of PCI Biotech is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than PCI Biotech. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile PCI Biotech Holding is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PCI Biotech Holding. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Complementary Tools for PCI Stock analysis
When running PCI Biotech's price analysis, check to measure PCI Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PCI Biotech is operating at the current time. Most of PCI Biotech's value examination focuses on studying past and present price action to predict the probability of PCI Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PCI Biotech's price. Additionally, you may evaluate how the addition of PCI Biotech to your portfolios can decrease your overall portfolio volatility.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |